| Female Reproductive System Squamous Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 41show all (up to 200) |
|---|
| → investigated in trials for | Cisplatinsmall molecule 28 trials (6 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |